All posts tagged "FDA approval"

Featured11 months ago

Clean Vision Corp (OTC: CLNV): Overcoming the Plastic Waste Crisis

Featured11 months ago

Meta Materials (NASDAQ: MMAT): More Due Diligence and Exploring Latest Developments

Featured11 months ago

Integrated Cannabis Solutions’ (OTC: IGPK) 633% Surge: Exploring Catalysts, Company Overview, and Growth Potential in 2024

Featured11 months ago

Sonoma Pharmaceuticals (NASDAQ: SNOA): Potential Surge to Speculations – What Lies Ahead?

Featured11 months ago

1847 Holdings (NYSE: EFSH) Soars: Insights, Acquisitions, and What Lies Ahead

Featured12 months ago

Spooz, Inc. (OTC: SPZI): Decoding the 7800% Surge and Unseen Potential

Featured12 months ago

Rainmaker Worldwide (OTC: RAKR): Exploring Recent Fluctuations & Strategic Acquisition

Featured12 months ago

Nitches’ (OTC: NICH) Expansion Roadmap: Latest Developments & What to Expect in 2024

Energy & Resources1 year ago

Buyer Group International’s (OTC: BYRG) Journey: Unearthing Potential with Strategic Exploration

Featured1 year ago

Understanding ECGI Holdings’ (OTC: ECGI) Surge: Exploring the Recent Developments and What Lies Ahead

Emerging Markets1 year ago

Bitfarms (NASDAQ: BITF) in Focus: Exploring the Meteoric 110% Surge and Macro Influences

Featured1 year ago

The Crypto Company (OTC: CRCW) Skyrockets 1000%: Understanding the Surge and Potential Impact

Featured1 year ago

BlockQuarry Corp’s (OTC: BLQC) Exponential Growth: Understanding the Phenomenon

BioPharma1 year ago

Brainstorm Cell Therapeutics’ (NASDAQ: BCLI) Post-Setback Resurgence: Unpacking FDA Impact & Market Expectations

Energy & Resources1 year ago

iSun, Inc (NASDAQ: ISUN) on the Rise: Recent Market Growth & Remarkable Momentum

Featured1 year ago

Uncovering CS Diagnostics (OTC: FZRO): Behind the 117% Gain & Market Opportunity

BioPharma1 year ago

Apollomics (NASDAQ: APLM) Market Momentum: Pipeline Potential, Market Trends, and Retail Insights

BioPharma1 year ago

Processa Pharmaceuticals (NASDAQ: PCSA): Revolutionizing Cancer Treatment through Next-Generation Chemotherapies

Featured1 year ago

Boardroom Battles and AI Fears: The OpenAI Story Unfolded

Featured1 year ago

AB International Group (OTC: ABQQ) Beyond the Numbers: Strategic Evolution in the Entertainment Industry

Featured1 year ago

Star Alliance International (OTC:STAL): Unpacking the 340% Gain & Future Prospects

Emerging Markets1 year ago

Music Licensing Inc. (OTC: SONG): Unraveling the 1250% Surge and Current Valuation

Featured1 year ago

Novo Integrated Sciences (NASDAQ: NVOS): From 350% Peaks to Controversial Shifts and Potential Catalysts

Featured1 year ago

TG Therapeutics (NASDAQ: TGTX): Bullish Analysts & Breakthrough Treatment in Relapsing MS

Energy & Resources1 year ago

BlueFire Technology Corp. (OTC: BLFR): Bold Ambitions & Path to NASDAQ Uplisting

Featured1 year ago

A2Z Smart Technologies (NASDAQ: AZ): Unveiling the Future of Shopping & Global Expansion

Featured1 year ago

3DX Industries (OTC: DDDX): Revolutionizing Manufacturing & Government Contracts

Featured1 year ago

FingerMotion (NASDAQ: FNGR): Latest Developments and Ongoing Investigations

Energy & Resources1 year ago

“Nouveau Monde Graphite (NYSE: NMG): Leveraging China’s Restrictions on Graphite Exports

BioPharma1 year ago

SAB Biotherapeutics (NASDAQ: SABS): Makes Strides in Type 1 Diabetes

Featured1 year ago

Galera Therapeutics (NASDAQ: GRTX) in Focus: Exploring Catalysts Ahead of FDA’s Verdict

BioPharma1 year ago

Nkarta Inc. (NASDAQ: NKTX): Breakthrough in NK Cell Therapy for Lupus Nephritis

Featured1 year ago

Astra Energy (OTCQB: ASRE): Pioneering Renewable Power and Market Momentum

Featured1 year ago

Meta Materials’ (NASDAQ:MMAT) Journey: Legal Hurdles, Innovation and Future Potential

BioPharma1 year ago

Tempest Therapeutics (NASDAQ: TPST) Soars 2,879%: From Downturn to Breakthrough in Clinical Trials

Featured1 year ago

Splash Beverage’s (NYSE: SBEV) Meteoric Surge: Can It Rival Beverage Industry Giants?

Featured1 year ago

Clean Vision Corporation (OTC: CLNV): Understanding the 180% Surge and Key Insights

Featured1 year ago

Orchard Therapeutics’ (NASDAQ: ORTX) Shares Skyrocket: How To Predict Biotech M&A

BioPharma1 year ago

Vivos Therapeutics (NASDAQ: VVOS) Strategic Moves: A Step Forward in Sleep Disorder Solutions

Featured1 year ago

IceCure Medical’s (NASDAQ: ICCM) ProSense: A 96.8% Success Rate Revolutionizing Breast Cancer Treatment

Featured1 year ago

T2 Biosystems (NASDAQ: TTOO) Breaks Ground: FDA Clearance, Market Trends, and Healthcare Impact

BioPharma1 year ago

Organogenesis (NASDAQ: ORGO): Latest Developments and Future Growth Prospects

Featured1 year ago

Femasys’ (NASDAQ: FEMY) FemaSeed Receives FDA Nod: A Game-Changer for Infertility Treatment

BioPharma1 year ago

Vaccitech (NASDAQ: VACC) Gains Unprecedented Support—What’s Behind It?

Featured1 year ago

MSP Recovery (NASDAQ: LIFW) in the Spotlight: Legal Battles, Luxe Living, and Stock Surge

Featured1 year ago

Solowin Holdings (NASDAQ: SWIN) 95% Stock Rally: Analyzing the Market Hype and IPO Impact”

BioPharma1 year ago

Advancing Medical Frontiers: Elutia Inc.’s(NASDAQ: ELUT) Strategic Vision in a $600 Million Market

Featured1 year ago

FingerMotion, Inc. (NASDAQ: FNGR): A Closer Look at its 500% Surge

Featured1 year ago

Navigating the Green Wave: US Cannabis ETF (NYSE: MSOS) A Closer Look at Cannabis Stock Resurgence

Featured1 year ago

First Wave BioPharma’s (NASDAQ: FWBI) Exclusive License: Repurposing Capeserod for GIT Disorder Solutions

Featured11 months ago

Clean Vision Corp (OTC: CLNV): Overcoming the Plastic Waste Crisis

Featured11 months ago

Meta Materials (NASDAQ: MMAT): More Due Diligence and Exploring Latest Developments

Featured11 months ago

Integrated Cannabis Solutions’ (OTC: IGPK) 633% Surge: Exploring Catalysts, Company Overview, and Growth Potential in 2024

Uncategorized2 years ago

Meta Materials Inc (OTCMKTS: MMTLP) Enormous Short Position in Trouble as Next Bridge Hydrocarbons Set to Stop Trading (George Palikaras & John Brda on Corporate Action)

Micro Cap Insider3 years ago

Medium (KOK PLAY) The Parabolic Rise of Metal Arts (OTCMKTS: MTRT)

Media & Technology4 years ago

Healthier Choices Management Corp. (OTCMKTS: HCMC) Powerful Comeback Brewing as PMI Patent Infringement Lawsuit Moves Forward